About this Research Topic
Omics are a high-throughput and versatile method to study various diseases, such as cardiometabolic disease. And new advances in omics technologies, for example third-generation sequencing and omics at single-cell resolution, are rapidly evolving. As a result, this research topic aims to call for researchers of cardiometabolic diseases from clinical medicine, basic medicine, bioinformatics, biomedical engineering and artificial intelligence together to share their latest studies of cardiometabolic diseases using omic technology.
In this Research Topic, deciphering the pathogenesis, subtyping, risk stratification, biomarkers or candidate druggable targets of a series of cardiometabolic diseases using genomics, epigenomics, (bulk, single-cell or spatial) transcriptome, proteomics, translatomics, metabolism, metagenomes, metaproteomics and other omics is within the scope. Meanwhile, integrating multi-omics, clinical indexes and/or biological experiments to systematically explore cardiometabolic disease will be great.
We hope this collection will contribute to our deeper understanding of cardiometabolic diseases, promoting the bench-to-bedside translation and precise medicine. Multiple types of manuscripts including original research articles, methods, reviews or mini-reviews are welcome.
Keywords: biomarkers, cardiometabolic diseases, bioinformatics, targets, genomics, omics
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.